Effectiveness of ultrasound-guided shockwave lithotripsy and predictors of its success rate in pediatric population: A report from a national reference center.


Journal

Journal of pediatric urology
ISSN: 1873-4898
Titre abrégé: J Pediatr Urol
Pays: England
ID NLM: 101233150

Informations de publication

Date de publication:
02 2021
Historique:
received: 12 06 2020
revised: 25 09 2020
accepted: 13 10 2020
pubmed: 7 11 2020
medline: 22 6 2021
entrez: 6 11 2020
Statut: ppublish

Résumé

Shockwave lithotripsy (SWL) remains a well-established treatment modality for many of the pediatric renal and ureteral stones. Repeated SWL sessions carry limitations due to the use of general anesthesia and X-ray radiation. The objective of our study was to evaluate stone-free rate (SFR) of 1-session of SWL for the management of pediatric renal and ureteral stones less than 2 cm performed exclusively under ultrasound guidance and identify factors influencing its success. The study utilized a retrospective cohort design including 124 consecutive pediatric patients with 133 renal and ureteral stones less than 2 cm whom SWL was performed in the period of January 2008 to December 2019. SWL procedures were performed by one expert surgeon in a single, national reference center, exclusively under ultrasound guidance using Modulith® SLK lithotripter. Follow-up was performed in post-SWL 2nd, 4th, 12th weeks and 6 months. The mean age of the children was 10 years (SD = 6.0) and the mean stone size was 10.4 mm (SD = 3.6 mm). Sedation type of anesthesia was used in 80 patients (64.5%). No major complication was developed, and no ureteral stenting was required in any of the patient following SWL. The SFR following 1-session of SWL was 88.0% at 12-week. Younger age (P = 0.002), sedation type of anesthesia (P = 0.001) and presence of radiolucent stones (P = 0.033) significantly improved post-SWL early stone clearance on univariate analysis, the latter being the only significant factor according to final model (P = 0.031). Ultrasound-guided SWL represents a safe and effective method for the management of both renal and ureteral stones in children. The SFR following 1-session of SWL at 12-weeks was achieved in 88.0%, the overall success rate after all SWL sessions reaching 91.7%. A higher success rate was observed in children harboring radiolucent stones.

Identifiants

pubmed: 33153916
pii: S1477-5131(20)30571-4
doi: 10.1016/j.jpurol.2020.10.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

78.e1-78.e7

Informations de copyright

Copyright © 2020 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest None.

Auteurs

Arthur Grabsky (A)

Department of Urology, Yerevan State Medical University, Yerevan, Armenia; Department of Urology, Izmirlian Medical Center, Yerevan, Armenia.

Arman Tsaturyan (A)

Department of Urology, Yerevan State Medical University, Yerevan, Armenia; Department of Urology, University Hospital of Bern, Bern, Switzerland. Electronic address: tsaturyanarman@yahoo.com.

Lusine Musheghyan (L)

Gerald and Patricia Turpanjian School of Public Health, American University of Armenia, Yerevan, Armenia.

Gevorg Minasyan (G)

Department of Urology, Yerevan State Medical University, Yerevan, Armenia.

Yervand Khachatryan (Y)

Department of Urology, Yerevan State Medical University, Yerevan, Armenia.

Gor Shadyan (G)

Department of Urology, Yerevan State Medical University, Yerevan, Armenia; Department of Urology, Izmirlian Medical Center, Yerevan, Armenia.

Artur Qocharyan (A)

Department of Urology, Yerevan State Medical University, Yerevan, Armenia; Department of Urology, Izmirlian Medical Center, Yerevan, Armenia.

Mkrtich Mosoyan (M)

Department of Urology and Robotic Surgery, Almazov National Medical Research Center, St. Petersburg, Russia.

Panagiotis Kallidonis (P)

Department of Urology, University General Hospital of Patras, Patras, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH